Creo Medical Group PLC Video abstracts re. Speedboat procedures in India
11 February 2020 - 6:00PM
RNS Non-Regulatory
TIDMCREO
Creo Medical Group PLC
11 February 2020
Creo Medical Group plc
("Creo" or the "Company")
Video abstracts featuring Speedboat procedures in India
Creo Medical Group plc (AIM: CREO), a medical device company
focused on the emerging field of surgical endoscopy, announces that
the Company's Speedboat device has featured in two newly published
video abstracts published by clinicians from the Asian Institute of
Gastroenterology, Hyderabad, India.
Both video abstracts were authored by experts in the field of
Gastrointestinal ("GI") therapeutic endoscopy for the Asian
Institute of Gastroenterology, Hyderabad, India. These procedures
follow on from the first in-human use of the Speedboat device in
India as announced in November last year, as well as additional
procedures in multiple sites in the US, UK, Spain, South Africa
and, more recently, Australia.
The first video abstract, published on Video GIE, the official
video journal of the American Society of Gastrointestinal
Endoscopy, is titled, "Peroral endoscopic myotomy in a patient with
failed Heller's myotomy by use of a novel bipolar radiofrequency
device." The abstract can be viewed on:
https://www.videogie.org/article/S2468-4481(19)30344-3/fulltext
The second video abstract, published via an open access content
publisher, Thieme Group, is titled, "Endoscopic dissection of an
esophageal submucosal tumor using a novel bipolar radiofrequency
device" and can be viewed online here:
https://www.thieme-connect.de/products/ejournals/html/10.1055/a-1089-7680
Craig Gulliford, Chief Executive Officer, commented: "We are
delighted to see physicians from different parts of the world not
only treating patients but quickly getting published in video form
which really highlights the power of advanced energy in the
flexible endoscopy setting. Particularly impressive is the size of
blood vessels which are being managed with ease using microwave
energy and our Speedboat where traditional technology would have
struggled even with multiple devices being deployed."
Creo Medical Group plc investors.creomedical.com
Richard Rees (CFO) +44 (0)1291 606 005
Cenkos Securities +44 (0)20 7397 8900
Stephen Keys / Cameron MacRitchie
(NOMAD)
Michael Johnson / Russell Kerr (Sales)
Walbrook PR Ltd Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: +44 (0)7980 541 893 / +44 (0)7515
909 238
About Creo Medical
Creo Medical, founded in 2003, is a medical device company
focused on the development and commercialisation of minimally
invasive surgical devices, by bringing advanced energy to
endoscopy. The Company's mission is to improve patient outcomes by
applying microwave and RF energy to surgical endoscopy. Creo has
developed CROMA, an electrosurgical Advanced Energy Platform that
combines bipolar radiofrequency for precise localised cutting and
microwave for controlled coagulation. This technology provides
clinicians with flexible, accurate and controlled surgical
solutions.
The Company's strategy is to bring its CROMA Advanced Energy
Platform powered by unique full spectrum adaptive technology to
market enabling a suite of medical devices which the Company has
designed, initially for the emerging field of GI therapeutic
endoscopy, an area with high unmet needs. The CROMA Advanced Energy
platform will be developed further for bronchoscopy and laparoscopy
procedures. The Company believes its technology can impact the
landscape of surgery and endoscopy by providing a safer,
less-invasive and more cost-efficient option of treatment.
For more information about Creo Medical please see our website,
investors.creomedical.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAGZGMZGGFGGZZ
(END) Dow Jones Newswires
February 11, 2020 02:00 ET (07:00 GMT)
Creo Medical (LSE:CREO)
Historical Stock Chart
From Apr 2024 to May 2024
Creo Medical (LSE:CREO)
Historical Stock Chart
From May 2023 to May 2024